Drug Information

Drug General Information
Drug ID
D03DSX
Former ID
DCL000643
Drug Name
SSR411298
Indication Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10:F32, F33, M32] Phase 2 [522544]
Company
Sanofi-Aventis
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [549823]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 522544ClinicalTrials.gov (NCT00822744) An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients. U.S. National Institutes of Health.
Ref 549823Pharma & Vaccines. Product Development Pipeline. April 29 2009.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.